Evidence map›Paper›PMID 24492422›Full record

ArticleTransplantation2014

Telomere length of recipients and living kidney donors and chronic graft dysfunction in kidney transplants.

William S Oetting, Weihua Guan, David P Schladt, Winston A Wildebush, Jennifer Becker, Bharat Thyagarajan, Pamala A Jacobson, Arthur J Matas, Ajay K Israni

Abstract readMulticenter Study
In one paragraph

Article in Transplantation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Senescence-induced p21Cell discovery · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Concepts of Genomics in Kidney Transplantation.Current transplantation reports · 2017
    Article
  9. Joint Assessment of Donor and Recipient hTERT Gene Polymorphism Provides Additional Information for Early Kidney Transplantation Outcomes.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
  10. Telomere Length Assessment for Prediction of Organ Transplantation Outcome. Future or Failure: A Review of the Literature.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

William S Oetting1 College of Pharmacy, University of Minnesota, Minneapolis, MN. 2 Division of Biostatistics, University of Minnesota, Minneapolis, MN. 3 Department of Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis, MN. 4 Minneapolis Medical Research Foundation, Minneapolis, MN. 5 Department of Laboratory Medicine and Pathology, University of Minnesota, Minnesota, MN. 6 Department of Surgery, University of Minnesota, Minneapolis, MN. 7 Address correspondence to: William S. Oetting, Ph.D., Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN 55455.
Weihua Guan
David P Schladt
Winston A Wildebush
Jennifer Becker
Bharat Thyagarajan
Pamala A Jacobson
Arthur J Matas
Ajay K Israni
University of Minnesota · USHennepin County Medical Center · USOrthopaedic Research Foundation · US

Funding

Pharmacogenomics of Immune Suppressants in Kidney TransplantationU19AI070119 · NIAID · UNIVERSITY OF MINNESOTA · PI MATAS, ARTHUR J · 2006 to 2016
$17.1M
Long-term Deterioration of Kidney Allograft FunctionU01AI058013 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MATAS, ARTHUR J · 2005 to 2010
$10.2M
NIAID NIH HHS 5U01-AI058013NIAID NIH HHS 5U19-AI070119NIAID NIH HHS U01 AI058013NIAID NIH HHS U19 AI070119
6 · The paper itself

Abstract

backgroundA biological marker that would allow clinicians to determine the length of time an allograft will remain functional after transplantation would greatly aid the ability to stratify donors by risk and to use biologically "young" allografts in young recipients, maximizing the use of this rare resource. Telomere length (TL) has been proposed to be such a marker to determine the biological age of a tissue.

methodsWe genotyped DNA from 1805 recipients and 1038 living kidney donors for TL to determine the association of TL with acute rejection (AR), chronic graft dysfunction (CGD), and graft failure of kidney allografts. DNA was isolated from peripheral blood white blood cells and TL was measured in DNA using the multiplexed monochrome quantitative polymerase chain reaction assay.

resultsAs has been previously shown, we found a significant association between log-transformed TL and donor age (P=3.8×10) and recipient age (P=5.6×10). Univariate and multivariate analysis did not show any significant associations between log-transformed TL in donor or recipient DNA with AR, CGD, or graft failure, although we did observe an association between donor chronological age and CGD (P=0.018).

conclusionAlthough older allografts have been shown to be at greater risk for AR and CGD, this does not appear to be associated with shorter TL. Different markers will need to be identified to determine how biological age impacts transplant outcome, such as age-related fibrosis or tubular atrophy and tubular loss.

Indexed as

AdultAgedAge FactorsBiomarkersDelayed Graft FunctionDNAFemaleGenotypeGraft RejectionGraft SurvivalHumansKidneyKidney TransplantationLeukocytesLiving DonorsMaleBiomarkersDNA

Identifiers

PMID24492422
PMCPMC4104656
OpenAlexW2074061290

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.